BackSAB Biotherapeutics- Warrants (25/07/2027) Overview

SAB Biotherapeutics- Warrants (25/07/2027) Total Assets

Latest total assets for SABSW: $240M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$238.21M
↑ 690.62% YoYΔ $208.08M vs prior year quarter

Peer trimmed avg / median

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Total Assets History

Loading

SAB Biotherapeutics- Warrants (25/07/2027) vs. peers: Total Assets Comparison

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) FAQ

As of the most recent data (June 2026), SABSW shows a total assets of $240M. That compares with $30M in the prior-year period — up 690.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SABSW's total assets is now $240M (was $30M) — a 690.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SAB Biotherapeutics- Warrants (25/07/2027) is outperforming or lagging.

Tracking SABSW's total assets over time shows whether SAB Biotherapeutics- Warrants (25/07/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $30M in the prior-year period — up 690.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has SAB Biotherapeutics- Warrants (25/07/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $240M) with ownership activity and broader fundamentals.